09/29/2026
What an inspiring day of collaboration, discovery and innovation in cancer care! 🎗️
ZSFG recently hosted the Cancer Research Symposium – bringing together researchers, clinicians and community leaders to explore how we can make cancer care more equitable, accessible and effective. The group shared research and QI involving social drivers of health, genetic testing, cancer screening, AI, clinical trials, and quality improvement.
We explored opportunities to reduce missed screening opportunities, expand access to research and clinical trials in the safety-net setting, and use innovation (including AI-powered risk stratification) to improve how patients access timely cancer care.
At ZSFG, innovation also means bringing specialized and emerging treatments to the under served communities we care for. Our Hematology/Oncology program combines complex cancer care with a commitment to reducing barriers, expanding access to clinical research and helping patients navigate the challenges of treatment. Just this year, the team brought the first bispecific antibody immunotherapy for lymphoma to ZSFG, a milestone in bringing cutting-edge cancer care to patients in the public health system.
From society to cell, prevention to treatment, and research to real-world care, the day highlighted what’s possible when our SF Public Health and UCSF School of Medicine teams come together at Zuckerberg San Francisco General around a shared commitment to health equity.
Thank you to all the researchers, clinicians, and staff who shared their work and sparked new ideas. We’re proud to be advancing cancer research and care – together. 💙